Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial

Konstantinos Dimopoulos; Dariusz Dudek; Federico Piscione; Waldemar Mielecki; Stefano Savonitto; Francesco Borgia; Ernesto Murena; Antonio Manari; Achille Gaspardone; Andrzej Ochala; Krzysztof Zmudka; Leonardo Bolognese; Philippe Gabriel Steg; Marcus Flather; Carlo Di Mario; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators

doi:10.1016/j.ijcard.2010.09.042

Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial

Konstantinos Dimopoulos, Dariusz Dudek, Federico Piscione, Waldemar Mielecki, Stefano Savonitto, Francesco Borgia, Ernesto Murena, Antonio Manari, Achille Gaspardone, Andrzej Ochala, Krzysztof Zmudka, Leonardo Bolognese, Philippe Gabriel Steg, Marcus Flather, Carlo Di Mario, CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Early angioplasty after thrombolysis is now recommended for ST-elevation myocardial infarction, but the current guidelines propose a wide time-window ranging between 3 and 24h after lytic administration. To identify the optimal timing for PCI after thrombolysis, we analyzed frequency and time course of the adverse events in patients randomized in the multicenter CARESS-in-AMI trial.

Original language	English
Pages (from-to)	275-81
Number of pages	7
Journal	International Journal of Cardiology
Volume	154
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2010.09.042
Publication status	Published - 9 Feb 2012

Keywords

Angioplasty, Balloon, Coronary
Female
Humans
Male
Middle Aged
Myocardial Infarction
Thrombolytic Therapy
Time Factors

Access to Document

10.1016/j.ijcard.2010.09.042

Cite this

Dimopoulos, K., Dudek, D., Piscione, F., Mielecki, W., Savonitto, S., Borgia, F., Murena, E., Manari, A., Gaspardone, A., Ochala, A., Zmudka, K., Bolognese, L., Steg, P. G., Flather, M., Di Mario, C., & CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators (2012). Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial. International Journal of Cardiology, 154(3), 275-81. https://doi.org/10.1016/j.ijcard.2010.09.042

@article{9181969078c84618bc0cbe8ce1101990,

title = "Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial",

abstract = "Early angioplasty after thrombolysis is now recommended for ST-elevation myocardial infarction, but the current guidelines propose a wide time-window ranging between 3 and 24h after lytic administration. To identify the optimal timing for PCI after thrombolysis, we analyzed frequency and time course of the adverse events in patients randomized in the multicenter CARESS-in-AMI trial.",

keywords = "Angioplasty, Balloon, Coronary, Female, Humans, Male, Middle Aged, Myocardial Infarction, Thrombolytic Therapy, Time Factors",

author = "Konstantinos Dimopoulos and Dariusz Dudek and Federico Piscione and Waldemar Mielecki and Stefano Savonitto and Francesco Borgia and Ernesto Murena and Antonio Manari and Achille Gaspardone and Andrzej Ochala and Krzysztof Zmudka and Leonardo Bolognese and Steg, {Philippe Gabriel} and Marcus Flather and {Di Mario}, Carlo and {CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators}",

year = "2012",

month = feb,

day = "9",

doi = "10.1016/j.ijcard.2010.09.042",

language = "English",

volume = "154",

pages = "275--81",

journal = "International Journal of Cardiology",

issn = "1874-1754",

publisher = "Elsevier",

number = "3",

}

Dimopoulos, K, Dudek, D, Piscione, F, Mielecki, W, Savonitto, S, Borgia, F, Murena, E, Manari, A, Gaspardone, A, Ochala, A, Zmudka, K, Bolognese, L, Steg, PG, Flather, M, Di Mario, C & CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators 2012, 'Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial', International Journal of Cardiology, vol. 154, no. 3, pp. 275-81. https://doi.org/10.1016/j.ijcard.2010.09.042

Timing of events in STEMI patients treated with immediate PCI or standard medical therapy : implications on optimisation of timing of treatment from the CARESS-in-AMI trial. / Dimopoulos, Konstantinos; Dudek, Dariusz; Piscione, Federico et al.

In: International Journal of Cardiology, Vol. 154, No. 3, 09.02.2012, p. 275-81.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Timing of events in STEMI patients treated with immediate PCI or standard medical therapy

T2 - implications on optimisation of timing of treatment from the CARESS-in-AMI trial

AU - Dimopoulos, Konstantinos

AU - Dudek, Dariusz

AU - Piscione, Federico

AU - Mielecki, Waldemar

AU - Savonitto, Stefano

AU - Borgia, Francesco

AU - Murena, Ernesto

AU - Manari, Antonio

AU - Gaspardone, Achille

AU - Ochala, Andrzej

AU - Zmudka, Krzysztof

AU - Bolognese, Leonardo

AU - Steg, Philippe Gabriel

AU - Flather, Marcus

AU - Di Mario, Carlo

AU - CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators

PY - 2012/2/9

Y1 - 2012/2/9

N2 - Early angioplasty after thrombolysis is now recommended for ST-elevation myocardial infarction, but the current guidelines propose a wide time-window ranging between 3 and 24h after lytic administration. To identify the optimal timing for PCI after thrombolysis, we analyzed frequency and time course of the adverse events in patients randomized in the multicenter CARESS-in-AMI trial.

AB - Early angioplasty after thrombolysis is now recommended for ST-elevation myocardial infarction, but the current guidelines propose a wide time-window ranging between 3 and 24h after lytic administration. To identify the optimal timing for PCI after thrombolysis, we analyzed frequency and time course of the adverse events in patients randomized in the multicenter CARESS-in-AMI trial.

KW - Angioplasty, Balloon, Coronary

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Thrombolytic Therapy

KW - Time Factors

U2 - 10.1016/j.ijcard.2010.09.042

DO - 10.1016/j.ijcard.2010.09.042

M3 - Article

C2 - 20961633

VL - 154

SP - 275

EP - 281

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 1874-1754

IS - 3

ER -